NLRP3 and cancer: Xu et al. have tested its inflammasome inhibiting potential in-vitro against P. gingivalis, the causative organism for gingivitis [37], and Alsaadi et al., have reported that in cancer cell lines, doxycycline is capable of suppressing NLRP3 derived inflammatory signals due to which it attenuates cancer cells growth [13].